Who are Midazolam and fentanyl's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/midazolam-and-fentanyl.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Midazolam and fentanyl — Competitive Intelligence Brief

Midazolam and fentanyl (Midazolam and fentanyl) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Benzodiazepine and opioid combination. Area: Anesthesia/Sedation.

marketed Benzodiazepine and opioid combination GABA-A receptor (midazolam); mu opioid receptor (fentanyl) Anesthesia/Sedation Small molecule Live · refreshed every 30 min

Target snapshot

Midazolam and fentanyl (Midazolam and fentanyl) — Corewell Health East. Midazolam and fentanyl together provide sedation and analgesia by enhancing GABAergic inhibition in the central nervous system and activating opioid receptors, respectively.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Midazolam and fentanyl TARGET	Midazolam and fentanyl	Corewell Health East	marketed	Benzodiazepine and opioid combination	GABA-A receptor (midazolam); mu opioid receptor (fentanyl)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Benzodiazepine and opioid combination class)

Corewell Health East · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Midazolam and fentanyl — Competitive Intelligence Brief. https://druglandscape.com/ci/midazolam-and-fentanyl. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab